Market brief — November 1, 2026

In 30 Seconds

• On Friday, October 30, technology stocks led a broad sell-off: the Nasdaq fell 2.86% and the S&P 500 declined 1.82% as earnings revived doubts about artificial-intelligence spending.^[1][3]
• The concern is shifting from demand to profitability: large technology companies continue investing heavily in data centers, while investors question when those investments will generate enough cash.^[1][2]
• The next few sessions may favor defensive sectors, but the market’s mixed breadth suggests that this is not yet a complete breakdown across all shares.

Last Session’s Figures

• CAC 40: 7,969.42, down 0.01%; broadly flat.
• Euro Stoxx 50: 6,131.31, down 1.22%; European shares followed the technology-led decline.
• DAX: 25,818.21, down 0.85%; German stocks weakened.
• S&P 500: 7,580.07, down 1.82%; sharpest decline since June, according to market reports.^[6][10]
• Nasdaq: 25,437.00, down 2.86%; technology stocks drove the retreat.^[3][6]

These are Friday’s closing levels, not prices for Sunday, November 1. A weekend separates that session from the next regular trading day.

The Day’s Main Topic, Explained

The central issue was the cost of the artificial-intelligence infrastructure boom. Microsoft, Amazon and Alphabet reported strong demand linked to cloud computing and artificial intelligence, but also signaled continued heavy investment in data centers and chips.^[1] Intel then issued a weaker fourth-quarter revenue outlook, citing pressure in personal computers and manufacturing bottlenecks.^[1][6]

Markets fall when expected profits appear less certain. A company can report rising sales but still disappoint shareholders if investment and borrowing rise faster than cash generation. The comparison is simple: a shop may be selling more products, but its expansion is worrying if the new stores consume more cash than they eventually earn.

Today’s Analysis

Friday’s decline was broad within the major United States indexes, but it was especially concentrated in technology and semiconductor shares. Intel fell 28.6%, while the Nasdaq lost 2.86%, showing that the reaction was not limited to one company.^[3][6] Amazon also declined after weaker-than-expected profit and renewed concern about its investment bill.^[6][10]

The scanner provides a useful counterpoint. Its latest reading was mixed: 52% of tracked shares stood above their 200-day average, while 47% were above their 50-day average. That is weaker than a healthy, broad advance, but it does not describe a market in which nearly every sector is falling.

The strongest signals appeared in tobacco, utilities, insurance, healthcare and pharmaceuticals. Altria Group, Exelon, Marsh & McLennan, Gilead Sciences and Pfizer therefore suggest that investors are seeking businesses with steadier demand or less direct exposure to the artificial-intelligence investment cycle. The most likely near-term scenario is continued volatility, with technology shares testing whether buyers return after the sharp fall. Stabilization would require better guidance on cash generation and investment returns. A further deterioration in earnings forecasts, especially from large technology companies, would invalidate that scenario and could extend the decline beyond technology.

Word of the Day

Free cash flow is the money left after a company pays operating costs and investment spending. For example, Amazon was reported to have used $42.4 billion of free cash flow over the previous 12 months while spending $94.8 billion on property and equipment, much of it linked to artificial intelligence.^[10]

What the Scanner Sees

• Altria Group (MO), tobacco: score exceptional at 45. The share price was above its highest level of the previous 20 sessions, with rising volume and strengthening trend indicators. This supports the defensive-sector theme.
• Exelon (EXC), utilities: score exceptional at 43. The price also exceeded its 20-session high, accompanied by higher volume. Utilities can appear more attractive when technology valuations and expected profits are under pressure.
• Gilead Sciences (GILD), biotechnology: score exceptional at 41. The scanner detected a 20-session high, rising volume and a strengthening trend. Healthcare’s presence confirms that market leadership is broadening away from large technology companies.

These signals are technical observations, not evidence that the companies will outperform. They confirm the shift toward selected defensive and healthcare groups, while the scanner also identified Fortive and DXC Technology, showing that the market is not moving in one direction.

Agenda

• The next United States economic and earnings releases: updated guidance will show whether the technology sell-off is spreading into broader profit expectations.
• Federal Reserve communication: any change in the outlook for interest rates could affect the value assigned to long-duration growth companies.
• European economic data and European Central Bank communication: inflation and growth signals could move European bond yields and the Euro Stoxx 50.
• Further corporate results: comments on data-center spending, debt and cash generation will remain central to technology valuations.

What to Watch

• A new reduction in technology earnings guidance could turn a sector correction into a broader United States market decline.
• Continued strength in utilities, healthcare and consumer staples would support the view that investors are rotating rather than abandoning equities altogether.

The figure to remember: Nasdaq down 2.86% on Friday, showing that doubts about the cost and profitability of artificial-intelligence investment have become a major market driver.